202 related articles for article (PubMed ID: 38355986)
1. Artificial intelligence in immunotherapy PET/SPECT imaging.
McGale JP; Chen DL; Trebeschi S; Farwell MD; Wu AM; Cutler CS; Schwartz LH; Dercle L
Eur Radiol; 2024 Feb; ():. PubMed ID: 38355986
[TBL] [Abstract][Full Text] [Related]
2. Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy.
McGale JP; Howell HJ; Beddok A; Tordjman M; Sun R; Chen D; Wu AM; Assi T; Ammari S; Dercle L
Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399425
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy.
Dercle L; McGale J; Sun S; Marabelle A; Yeh R; Deutsch E; Mokrane FZ; Farwell M; Ammari S; Schoder H; Zhao B; Schwartz LH
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180071
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy.
McGale J; Hama J; Yeh R; Vercellino L; Sun R; Lopci E; Ammari S; Dercle L
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835808
[TBL] [Abstract][Full Text] [Related]
5. Artificial Intelligence in Breast Cancer: A Systematic Review on PET Imaging Clinical Applications.
Alongi P; Rovera G; Stracuzzi F; Popescu CE; Minutoli F; Arnone G; Baldari S; Deandreis D; Caobelli F
Curr Med Imaging; 2023; 19(8):832-843. PubMed ID: 36703586
[TBL] [Abstract][Full Text] [Related]
6. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
7. PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review.
Urso L; Manco L; Castello A; Evangelista L; Guidi G; Castellani M; Florimonte L; Cittanti C; Turra A; Panareo S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362190
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence applications for oncological positron emission tomography imaging.
Li W; Liu H; Cheng F; Li Y; Li S; Yan J
Eur J Radiol; 2021 Jan; 134():109448. PubMed ID: 33307463
[TBL] [Abstract][Full Text] [Related]
9. The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers.
Liberini V; Laudicella R; Capozza M; Huellner MW; Burger IA; Baldari S; Terreno E; Deandreis D
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920423
[TBL] [Abstract][Full Text] [Related]
10. The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges.
Hu Q; Li K; Yang C; Wang Y; Huang R; Gu M; Xiao Y; Huang Y; Chen L
Front Oncol; 2023; 13():1133164. PubMed ID: 36959810
[TBL] [Abstract][Full Text] [Related]
11. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients.
Farina B; Guerra ADR; Bermejo-Peláez D; Miras CP; Peral AA; Madueño GG; Jaime JC; Vilalta-Lacarra A; Pérez JR; Muñoz-Barrutia A; Peces-Barba GR; Maceiras LS; Gil-Bazo I; Gómez MD; Ledesma-Carbayo MJ
J Transl Med; 2023 Mar; 21(1):174. PubMed ID: 36872371
[TBL] [Abstract][Full Text] [Related]
12. Radiomics of
Mu W; Tunali I; Gray JE; Qi J; Schabath MB; Gillies RJ
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1168-1182. PubMed ID: 31807885
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence applied to image-guided radiation therapy (IGRT): a systematic review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO).
Boldrini L; D'Aviero A; De Felice F; Desideri I; Grassi R; Greco C; Iorio GC; Nardone V; Piras A; Salvestrini V
Radiol Med; 2024 Jan; 129(1):133-151. PubMed ID: 37740838
[TBL] [Abstract][Full Text] [Related]
15. The promise of artificial intelligence and deep learning in PET and SPECT imaging.
Arabi H; AkhavanAllaf A; Sanaat A; Shiri I; Zaidi H
Phys Med; 2021 Mar; 83():122-137. PubMed ID: 33765602
[TBL] [Abstract][Full Text] [Related]
16. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review.
Lai Q; Spoletini G; Mennini G; Laureiro ZL; Tsilimigras DI; Pawlik TM; Rossi M
World J Gastroenterol; 2020 Nov; 26(42):6679-6688. PubMed ID: 33268955
[TBL] [Abstract][Full Text] [Related]
18. Clinical application of AI-based PET images in oncological patients.
Dai J; Wang H; Xu Y; Chen X; Tian R
Semin Cancer Biol; 2023 Jun; 91():124-142. PubMed ID: 36906112
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence-based radiomics in bone tumors: Technical advances and clinical application.
Meng Y; Yang Y; Hu M; Zhang Z; Zhou X
Semin Cancer Biol; 2023 Oct; 95():75-87. PubMed ID: 37499847
[TBL] [Abstract][Full Text] [Related]
20. Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art.
Manco L; Albano D; Urso L; Arnaboldi M; Castellani M; Florimonte L; Guidi G; Turra A; Castello A; Panareo S
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
